New GeoMap Tools Get Patient Recruitment Back on Track During the COVID-19 Outbreak
March 09 2020 - 6:30AM
JCN Newswire (English)
SAN FRANCISCO, CA, Mar 9, 2020 - (ACN Newswire) - Award-winning
global leader in digital patient recruitment GeoMap Clinical by
TrialWire announced today new tools added to the GeoMap
geo-targeting Platform that can restore and boost patient
recruitment numbers at a time when people are avoiding clinic
appointments for fear of COVID-19.
The GeoMap Platform is currently recruiting for clinical trials in
North America, Latin America, Australia, New Zealand, Asia and the
EU.
The company said:
"Most studies require at least 1 clinic visit for check-ups,
monitoring and tests, but many sponsors, investigators and study
coordinators are finding that potential patients are staying away
because of fear of contracting the virus in a clinic.
Increasingly people are also not traveling unless they really need
to - especially people with underlying conditions, which is much of
the potential clinical trial patient community."
The GeoMap Platform has introduced a range of new tools to recruit
patients as part of the GeoMap process which includes online
screening using the Proprietary AI Patient Screener Funnel of more
than 300+ possible questions, and direct secure encrypted contact
with the study coordinator for a phone call.
The Platform is the fastest most accurate targeting tool available
that doesn't require IRB/EC approval and can start recruiting in
under 24 hours.
The Platform had strict verification and email encryption so PHI is
managed in accordance with state and country regulatory
guidelines.
For a full briefing on the new recruitment support tools on the
GeoMap Clinical Platform, please click here:
https://www.geomap-clinicaltrialfinder.com/patient-recruitment-covid-19/
About GeoMap Clinical - https://www.trial-wire.com/
The GeoMap Clinical Platform is the world's most advanced
geo-location/targeting and AI platform powered by specialist
algorithms that find and screen the right people living or working
near sites.
The Platform is a sophisticated location and health profile search
service that sends only highly eligible people to their nearest
site.
It has been designed to end pain points across the clinical trials
sector saving time and money at every stage, while ensuring patient
privacy and regulatory compliance.
The GeoMap Clinical Platform is not a database builder. Patient ID
is redacted instantly and the focus is instead on finding only
motivated patients to support enrollment and retention.
For a briefing, please see
www.geomap-clinicaltrialfinder.com/patient-recruitment-covid-19/
Media Contact:
Chris Thompson
team@dmgpr.com
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427
Source: GeoMap Clinical
Copyright 2020 ACN Newswire . All rights reserved. |
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024